A Chinese cancer drug has just been approved in the US, but it will cost over 30 times more, with two others predicted to ...
Nov 15 (Reuters) - The U.S. Food and Drug Administration (FDA) has approved Bristol-Myers Squibb's (BMY.N) lung cancer drug that was acquired as part of the company's $4.1 billion buyout of ...
Immunotherapy is finding use in more cancers and as an earlier line of cancer treatment, as Bristol Myers Squibb knows well with its three FDA-approved checkpoint inhibitors. But for some cancers ...
Drugmakers are seeking to limit their reliance on Chinese contractors who produce drugs used in clinical trials and ...
The most common type of breast cancer now has a new targeted treatment: an AstraZeneca drug that’s first in a new class of therapies addressing a certain genetic signature. But the new approval ...
Nov 16 (Reuters) - The U.S. Food and Drug Administration on Thursday approved AstraZeneca's AZN.L drug capivasertib in combination with an older drug, providing another treatment option for ...
WASHINGTON (TND) — The Food and Drug Administration is screening all cinnamon imports arriving in the U.S. from different countries after multiple reports of children falling ill from lead ...
The U.S. Food and Drug Administration is screening imports of cinnamon from multiple countries for toxic lead The U.S. Food and Drug Administration is screening imports of cinnamon from multiple ...
(Reuters) -The U.S. Food and Drug Administration on Thursday approved AstraZeneca's Truqap in combination with an older drug, providing another treatment option for patients with the most common type ...
